We are live on ! Find out more
OPRX icon

OptimizeRx
OPRX

64 hedge funds and large institutions have $109M invested in OptimizeRx in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

67% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 15

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more funds holding

Funds holding: 56 → 64 (+8)

5.76% more ownership

Funds ownership: 47.58% → 53.34% (+5.8%)

4% more capital invested

Capital invested by funds: $106M → $109M (+$3.84M)

3% less call options, than puts

Call options by funds: $1.24M | Put options by funds: $1.27M

Holders
64
Holders Change
+8
Holders Change %
+14.29%
% of All Funds
1.4%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
14
Increased
25
Reduced
15
Closed
6
Calls
$1.24M
Puts
$1.27M
Net Calls
-$34K
Net Calls Change
+$539K

Top Buyers

1
GIPM
G2 Investment Partners Management
New York
+$4.94M
2
BlackRock
BlackRock
New York
+$2.6M
3
CCM
Cadence Capital Management
Massachusetts
+$2.46M
4
TAM
THB Asset Management
Connecticut
+$2.28M
5
Northern Trust
Northern Trust
Illinois
+$2.1M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$1.53M
2
MHP
Manatuck Hill Partners
Connecticut
-$1.38M
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$868K
4
Renaissance Technologies
Renaissance Technologies
New York
-$520K
5
1CM
1492 Capital Management
Wisconsin
-$464K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAWC
26
P.A.W. Capital
Connecticut
$579K +$619K +40,000 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$547K +$118K +7,602 +25%
Charles Schwab
28
Charles Schwab
California
$464K +$62.2K +4,022 +14%
GIP
29
Granite Investment Partners
California
$446K – – –
Squarepoint
30
Squarepoint
New York
$391K +$83.6K +5,400 +25%
Bank of America
31
Bank of America
North Carolina
$377K +$35.4K +2,285 +10%
Wells Fargo
32
Wells Fargo
California
$323K +$137K +8,856 +65%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$311K +$47.2K +3,049 +17%
Allianz Asset Management
34
Allianz Asset Management
Germany
$310K -$452K -29,223 -58%
GA
35
Geller Advisors
New York
$290K +$310K +20,000 New
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$284K +$303K +19,591 New
PPA
37
Parametric Portfolio Associates
Washington
$262K +$280K +18,076 New
PI
38
PEAK6 Investments
Illinois
$260K +$278K +17,990 New
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$203K +$201K +12,973 +1,297%
AQR Capital Management
40
AQR Capital Management
Connecticut
$203K +$217K +14,017 New
UBS Group
41
UBS Group
Switzerland
$182K +$162K +10,441 +483%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$177K – – –
Barclays
43
Barclays
United Kingdom
$151K +$41.4K +2,678 +35%
AIM
44
Alambic Investment Management
California
$150K +$160K +10,330 New
WG
45
Winton Group
United Kingdom
$149K +$159K +10,302 New
WMC
46
Westwood Management Corporation
Illinois
$145K – – –
PNC Financial Services Group
47
PNC Financial Services Group
Pennsylvania
$136K +$144K +9,332 New
AIG
48
American International Group
New York
$126K +$16.9K +1,093 +14%
AG
49
Advisor Group
Arizona
$114K – – –
CT
50
Clearstead Trust
Maine
$113K – – –
1
2
3

OPRX Hedge Fund Activity: Q3 2019 in Review

64 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2019, worth a combined $109M — up 3.6% from $106M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new OPRX positions and 6 closed out — a net gain of 8 holders — while 25 added to existing stakes and 15 trimmed.

The largest buyer was G2 Investment Partners Management, adding an estimated $4.94M. The largest seller was Marshall Wace, exiting entirely with an estimated $1.53M sold.

  • 64 institutional investors held OptimizeRx (OPRX) as of Q3 2019, up from 56 in Q2 2019.
  • Funds reported $109M of OptimizeRx stock for Q3 2019, up 3.6% quarter-over-quarter.
  • 14 funds opened new OptimizeRx positions in Q3 2019 and 6 closed out, a net change of +8 holders.
  • The largest OptimizeRx buyer in Q3 2019 was G2 Investment Partners Management, an estimated $4.94M added.
  • The largest OptimizeRx seller in Q3 2019 was Marshall Wace, an estimated $1.53M sold.

Based on aggregated 13F filings for Q3 2019.